Article abstract-Eighty-five patients with refractory transformed migraine type of chronic daily headache (CDH) had spinal tap as a part of diagnostic work-up. Twelve had increased intracranial pressure without papilledema, transient visual obscurations, ,or visual field defects. The headache profile of these 12 patients was not different from that of transformed migraine type of CDH. Acute headache exacerbations responded to specific antimigraine agents such as ergotamine, dihydroergotamine (DHE), and sumatriptan, whereas prophylactic antimigraine medications were only partially helpful. Addition of agents such as acetazolamide and furosemide, after the diagnosis of increased intracranial pressure, resulted in better control of symptoms. These observations suggest a link between migraine and idiopathic intracranial hypertension that needs further research. In refractory CDH with migrainous features, a spinal tap to exclude coexistent idiopathic intracranial hypertension without papilledema may be indicated.
Article abstract-Eighty-five patients with refractory transformed migraine type of chronic daily headache (CDH) had spinal tap as a part of diagnostic work-up. Twelve had increased intracranial pressure without papilledema, transient visual obscurations, ,or visual field defects. The headache profile of these 12 patients was not different from that of transformed migraine type of CDH. Acute headache exacerbations responded to specific antimigraine agents such as ergotamine, dihydroergotamine (DHE), and sumatriptan, whereas prophylactic antimigraine medications were only partially helpful. Addition of agents such as acetazolamide and furosemide, after the diagnosis of increased intracranial pressure, resulted in better control of symptoms. These observations suggest a link between migraine and idiopathic intracranial hypertension that needs further research. In refractory CDH with migrainous features, a spinal tap to exclude coexistent idiopathic intracranial hypertension without papilledema may be indicated. NEUROLOGY 1996; 46:1226 -1230 Headache, papilledema, and elevated CSF pressure above 200 mm of water in a patient with normal neurologic examination and neuro-imaging meet the International Headache Society (IHS) diagnostic criteria for idiopathic intracranial hypertension (IIH).l Transient visual obscurations (TVOs), diplopia, vi--sual loss, and noises in the head can occur in many of these patients.>" Papilledema is the most consistent neurologic sign of IIH but, rarely, IIH can occur without papilledema. [7] [8] [9] [10] Headache is the most common symptom of IIH, occurring in 90% of patients.>" and on a daily basis in 75%.11 Although there has been considerable attention given to the visual symptomatology or'IIH, only one study has detailed the headache profile. Pulsatile, predominantly focal (retro-ocular), some-, times generalized headache, waking the patient up in the morning, with nausea and vomiting, occurred in the majority.'! .This 'headache profile is not strikingly different from-that of migraine."
Corbett" and
Sorenson and Corbett= noted that preexisting migraine may worsen with IIH, and prophylactic migraine drugs, especially beta blockers and naproxen sodium, are useful in the treatment of headache from intracranial hypertension.
In a related condition, ------. _ namely slit ventricle syndrome, antimigraine agents were highly effective in controlling headache.> Ramadan-" reported transformation of episodic migraine into chronic daily headache (CDH) in a patient who developed IIH without papilledema. Marcelis and Silberstein'? described 10 patients with IIH without papilledema who presented with CDH. Many of their patients had a headache profile similar to that of migraine and were treated with antimigraine agents. Silberstein and Corbett." emphasized the importance of performing lumbar puncture in patients with intractable CDH to rule out IIH without papilledema,
Patients. The H~uston Headache Clinic is a referral center. We use uniform standardized forms to obtain headache, general medical, neurologic, and family histories. Information regarding comorbid and trigger factors is also recorded in the intake form. The interviews and physical and neurologic examinations were conducted by neurologists, both initially and on follow-up visits.
Among the patients with the transformed migraine type of CDH17,18 treated at the Houston Headache Clinic between 1986 and 1993, 85 who were considered refractory form the cases for the present study. All these patients gave a history of migraine in the past but developed daily headache subsequently. All patients had daily headache at the time of study. The response to abortive antimigraine agents such as ergotamine, sumatriptan, and dihydroergotamine (DHE) during acute phases were satisfactory in most of these patients but, over time, their daily headaches persisted. They developed repeated prolonged periods of very frequent severe migraine-like and nondescript headaches resulting in over-medication. This resulted in frequent clinic and emergency room visits and sometimes hospitalization. This group of 85 chronic refractory patients was subjected to. lumbar puncture as part of a further work-up to rule out chronic meningitis or increased intracranial pressure. All patients had normal CT or MRI.
After obtaining informed consent, lumbar puncture was performed with patients positioned in the lateral decubitus position on a level surface. A standard 20-gaugEi spinal needle was used with the manometer positioned' at a 90-degree angle to the spinal cord. The opening pressure was measured with the patient's knee and hips in the extended position and neck straightened.
Patients with elevated CSF pressure were treated with
